ホーム › PubMed Lab 🤖 自分の AI で使う ⭐ 保存した論文

🔬 PubMed Lab

日本語で入力するだけで、PubMed の英語論文を検索できるリサーチアシスタントです。
卒論・研究テーマ探し、興味のある論文を効率よく見つけられます。

「マイクロバイオーム治療、欧州で規制枠組みが転換期」の検索結果

273 件中 10 件を表示 (3823 ms) · ⭐ 保存した論文

AI が生成した英語クエリを見る
(microbiome therapy[MeSH] OR microbiome treatment OR microbiota therapy OR FMT OR fecal microbiota transplantation) AND (Europe OR European Union OR EU) AND (regulation OR regulatory framework OR policy)

💡 マイクロバイオーム治療と欧州の規制に関する検索。FMTや関連用語を含め、規制枠組みに焦点を当てました。

🎓 卒論・修論テーマを AI が提案

この 5 本の論文を俯瞰して、あなたが実際に卒論・修論で研究できるテーマを 3 つ提案します。

残り 3 / 3 回 (今日)

📖 このサイトの解説記事から (日本語で読める)

PubMed Trivia が過去に取り上げた論文を日本語で解説している記事です。

🔍 PubMed の検索結果

  • Editor's briefing.

    Roger Jones · The British journal of general practice : the journal of the Royal College of General Practitioners · 2014

    📄 PubMed で読む (PMID: 24567624)
  • Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I.

    Valentina Ferrari, Antonino Lo Cascio, Alessia Melacarne 他 · Cancer cell · 2023

    Recent data have shown that gut microbiota has a major impact on the clinical response to immune checkpoint inhibitors (ICIs) in the context of solid tumors. ICI-based therapy acts by unlocking cognate cytotoxic T lymphocyte (CTL) effector responses, and increased sensitivity to ICIs is due to an enhancement of patients' tumor antigen (TA)-specific CTL responses. Cancer clearance by TA-specific CT…

    📄 PubMed で読む (PMID: 37738976)
  • Global evolution of inflammatory bowel disease across epidemiologic stages.

    Lindsay Hracs, Joseph W Windsor, Julia Gorospe 他 · Nature · 2025

    During the twentieth century, inflammatory bowel disease (IBD) was considered a disease of early industrialized regions in North America, Europe and Oceania1. At the turn of the twenty-first century, IBD incidence increased in newly industrialized and emerging regions in Africa, Asia and Latin America, while the prevalence in early industrialized regions continued to grow steadily2-4. Changes in t…

    📄 PubMed で読む (PMID: 40307548)
  • Gut Microbiota Composition Is Related to AD Pathology.

    Barbara J H Verhaar, Heleen M A Hendriksen, Francisca A de Leeuw 他 · Frontiers in immunology · 2021

    Several studies have reported alterations in gut microbiota composition of Alzheimer's disease (AD) patients. However, the observed differences are not consistent across studies. We aimed to investigate associations between gut microbiota composition and AD biomarkers using machine learning models in patients with AD dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD).…

    📄 PubMed で読む (PMID: 35173707)
  • Gut microbiome compositional and functional features associate with Alzheimer's disease pathology.

    Jea Woo Kang, Lora A Khatib, Margo B Heston 他 · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

    The gut microbiome is a potentially modifiable risk factor for Alzheimer's disease (AD); however, understanding of its composition and function regarding AD pathology is limited. Shallow-shotgun metagenomics was used to analyze the fecal microbiome of participants in the Wisconsin Microbiome in Alzheimer's Risk Study, leveraging clinical data and cerebrospinal fluid (CSF) biomarkers. Differential …

    📄 PubMed で読む (PMID: 40604345)
  • Inulin-gel-based oral immunotherapy remodels the small intestinal microbiome and suppresses food allergy.

    Kai Han, Fang Xie, Olamide Animasahun 他 · Nature materials · 2024

    Despite the potential of oral immunotherapy against food allergy, adverse reactions and loss of desensitization hinder its clinical uptake. Dysbiosis of the gut microbiota is implicated in the increasing prevalence of food allergy, which will need to be regulated to enable for an effective oral immunotherapy against food allergy. Here we report an inulin gel formulated with an allergen that normal…

    📄 PubMed で読む (PMID: 38977883)
  • Empirical antibiotic therapy for sepsis: save the anaerobic microbiota.

    Robert F J Kullberg, Bastiaan W Haak, Rishi Chanderraj 他 · The Lancet. Respiratory medicine · 2025

    Antibiotics are fundamental in sepsis management; however, the optimal empirical treatment remains debated. Despite anaerobes rarely being the causative pathogen of sepsis, antibiotics targeting them are frequently used, which might lead to unintended consequences. Multiple studies have shown that depletion of commensal anaerobic gut microbes by anti-anaerobic antibiotics influences systemic immun…

    📄 PubMed で読む (PMID: 39401510)
  • Evidence that the endometrial microbiota has an effect on implantation success or failure.

    Inmaculada Moreno, Francisco M Codoñer, Felipe Vilella 他 · American journal of obstetrics and gynecology · 2016

    Bacterial cells in the human body account for 1-3% of total body weight and are at least equal in number to human cells. Recent research has focused on understanding how the different bacterial communities in the body (eg, gut, respiratory, skin, and vaginal microbiomes) predispose to health and disease. The microbiota of the reproductive tract has been inferred from the vaginal bacterial communit…

    📄 PubMed で読む (PMID: 27717732)
  • Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.

    Selina R Cox, James O Lindsay, Sébastien Fromentin 他 · Gastroenterology · 2020

    There is limited evidence that a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) reduces gut symptoms in quiescent inflammatory bowel disease (IBD). We performed a randomized, controlled trial to investigate the effects of a low FODMAP diet on persistent gut symptoms, the intestinal microbiome, and circulating markers of inflammation in patients with…

    📄 PubMed で読む (PMID: 31586453)
  • Hypericum perforatum L. attenuates depression by regulating Akkermansia muciniphila, tryptophan metabolism and NFκB-NLRP2-Caspase1-IL1β pathway.

    Zheng-Meng Jiang, Fang-Fang Wang, Yuan-Yuan Zhao 他 · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024

    Gut microbiota dysbiosis significantly contributes to progression of depression. Hypericum perforatum L. (HPL) is traditionally used in Europe for treating depression. However, its mechanism remains largely underexplored. This study aims to investigate the pivotal gut microbiota species and microbial signaling metabolites associated with the antidepressant effects of HPL. Fecal microbiota transpla…

    📄 PubMed で読む (PMID: 38996505)